[Diabetes-Talk] Fwd: Important information about Dexcom G7 and Tandem

gmelconian619 at gmail.com gmelconian619 at gmail.com
Thu Feb 9 02:06:01 UTC 2023


Patricia, interesting developments. Please do let us know how this works .  

 

From: Diabetes-Talk <diabetes-talk-bounces at nfbnet.org> On Behalf Of Patricia Maddix via Diabetes-Talk
Sent: Wednesday, February 8, 2023 4:50 PM
To: NFB Diabetes Division <Diabetes-Talk at nfbnet.org>
Cc: Patricia Maddix <pmaddix at comcast.net>
Subject: [Diabetes-Talk] Fwd: Important information about Dexcom G7 and Tandem

 

FYI.

 

 

 

Sent from my iPhone


Begin forwarded message:

From: Tandem Cares <tandemcares at tandemdiabetes.com <mailto:tandemcares at tandemdiabetes.com> >
Date: February 8, 2023 at 4:07:43 PM PST
To: pmaddix at comcast.net <mailto:pmaddix at comcast.net> 
Subject: Important information about Dexcom G7
Reply-To: tandemcares at tandemdiabetes.com <mailto:tandemcares at tandemdiabetes.com> 

 

A note from Tandem Diabetes Care




	


  <https://go.tandemdiabetes.com/rs/348-RXV-705/images/logo-tandem-diabetes-care-horizontal-rgb.png> 

	



t:slim X2 insulin pump + Dexcom G7 integration

	

 

	



Dear Tandem Family member,

 

Dexcom is launching the G7 continuous glucose monitoring (CGM) system. We know you’re excited. We are too!

 

We’re working hard to make sure the t:slim X2 insulin pump with Control‑IQ technology integrates with the Dexcom G7. For now, it’s important to know that the Dexcom G7 will not work with the t:slim X2 pump (yet).

 

The best way to stay in the know is to sign up for updates on our Tandem-Dexcom G7 page. Please know that our customer service support team does not have any additional information and can’t answer questions about G7 integration.

	

 

	



 <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK5xJDZpNgIvCpbxENPNaL6vO2n3c4CtYu80plA2d2aRdzd7LOJAjmFoBPGuxmJo0As9Q=> Sign up now 

	

 

	



Tandem has previously communicated that our goal is to launch our integrated offerings within one to two quarters (3-6 months) of Dexcom G7 receiving FDA clearance. We will provide updates on t:slim X2 pump and sensor integration. In the meantime, please continue to use the Dexcom G6 system.

 

Reminder: Please make it clear during your next CGM supply order that you use a CGM-integrated Tandem pump so you can continue receiving CGM supplies that work with your pump.

 

Thanks for being part of the Tandem Family.

	

 

	

	
	

 

	



Important Safety Information: RX ONLY. The t:slim X2 pump and Control-IQ technology are intended for single patient use. The t:slim X2 pump and Control-IQ technology are indicated for use with U-100 insulin only. t:slim X2 insulin pump: The t:slim X2 insulin pump with interoperable technology is an alternate controller enabled (ACE) pump that is intended for the subcutaneous delivery of insulin, at set and variable rates, for the management of diabetes mellitus in people requiring insulin. The pump is able to reliably and securely communicate with compatible, digitally connected devices, including automated insulin dosing software, to receive, execute, and confirm commands from these devices. The t:slim X2 pump is indicated for use in individuals six years of age and greater. Control-IQ technology: Control-IQ technology is intended for use with a compatible integrated continuous glucose monitor (iCGM, sold separately) and ACE pump to automatically increase, decrease, and suspend delivery of basal insulin based on iCGM readings and predicted glucose values. It can also deliver correction boluses when the glucose value is predicted to exceed a predefined threshold. Control-IQ technology is intended for the management of Type 1 diabetes mellitus in persons six years of age and greater.

 

	
	
WARNING: Control-IQ technology should not be used by anyone under the age of six years old. It should also not be used in patients who require less than 10 units of insulin per day or who weigh less than 55 pounds.

	
	

 

Control-IQ technology is not indicated for use in pregnant women, people on dialysis, or critically ill patients. Do not use Control-IQ technology if using hydroxyurea. Users of the t:slim X2 pump and Control-IQ technology must: use the insulin pump, CGM, and all other system components in accordance with their respective instructions for use; test blood glucose levels as recommended by their healthcare provider; demonstrate adequate carb-counting skills; maintain sufficient diabetes self-care skills; see healthcare provider(s) regularly; and have adequate vision and/or hearing to recognize all functions of the pump, including alerts, alarms, and reminders. The t:slim X2 pump, and the CGM transmitter and sensor must be removed before MRI, CT, or diathermy treatment. Visit  <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK56YnJ6bRXZuOgYrLkdbfYIjjWQchx-BBVI7BcoYqpWknGyDLLBFBDsw002WONo0DeXI=> tandemdiabetes.com/safetyinfo for additional important safety information.

 

©2023 Tandem Diabetes Care, Inc. All rights reserved. Tandem Diabetes Care, Control-IQ, and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries. Dexcom, Dexcom G6, and Dexcom G7 are either registered trademarks or trademarks of Dexcom, Inc. in the United States and/or other countries. All third-party marks are the property of their respective owners. CM-002680_A

	

 

	

	


  <https://go.tandemdiabetes.com/rs/348-RXV-705/images/logo-tandem-diabetes-care-horizontal-white.png> 



 <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK5xJDZpNgIvCpbxENPNaL6vO2n3c4CtYu80plA2d2aRdzd7LOJAjmFoBPGuxmJo0As9Q=> Sign up now 

 

	

       <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK5ybYuN8mQvyhTtBztpgcevNlN1OWrSLx3aWAkQp8F8qlH2ei5i0g6LU2TuFYv2Tu6fk=>    <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK55LVvMm29BL3_lUdIiBrKQzCrOYcAWCaD4AEIq_jCTDOiGkmIC6JZT5nRLsENDTn890=>    <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK53r49R8l5w_LCW84X-3CETrsvOJQvHVgqIltJlIxaWsRCx9hE67yXtO3AfwngkwMnbo=>    <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK5w47UecXKJjzTnuW6duNJxx7eMa7CZO3auruMBGR0nID039tX51Oe0oceOtR_5eGXGw=>    <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK5_xv6LLtz9ejRZJucbnRmkQXs9e9RNMYPljueF-MddIztGZ93PRNEfY5e1-XBDtL_K8=>       

	

 

	
	


Tandem Diabetes Care respects your  <http://info.tandemdiabetes.com/MzQ4LVJYVi03MDUAAAGJ0niK51M_OwWxkCoGJH1_zZ-XsOH3uCKnL4O6fYOyW8dejqzD-p4ol2shiHHSBSuv5dUoPvA=> privacy. This email was sent to pmaddix at comcast.net <mailto:pmaddix at comcast.net> . If you no longer wish to receive these emails, you may  <https://go.tandemdiabetes.com/email_subscription_mgmt.html?mkt_unsubscribe=1&mkt_tok=MzQ4LVJYVi03MDUAAAGJ0niK5w3kbl0rp6oGStmdkI2KvmF3ixt6Ux17_8ulteyz_1WT1yBlp2UzN27wk8wisPe2SwItI1Ms1z4vh5IOOlLi-sGNMPpuLjjPUx1L3A> unsubscribe at any time. 

 

11075 Roselle Street ❯❯❯ San Diego, CA 92121 ❯❯❯ USA

	




 <https://go.tandemdiabetes.com/index.php/email/emailWebview?mkt_tok=MzQ4LVJYVi03MDUAAAGJ0niK5w3kbl0rp6oGStmdkI2KvmF3ixt6Ux17_8ulteyz_1WT1yBlp2UzN27wk8wisPe2SwItI1Ms1z4vh5IOOlLi-sGNMPpuLjjPUx1L3A&md_id=6997> View as Webpage 

	
	

  <https://s3.amazonaws.com/msv5/images/spacer.gif>   



More information about the Diabetes-Talk mailing list